Bavencio

Merck KGaA takes back control of PD-L1 cancer drug as Pfizer alliance ends
Merck KGaA takes back control of PD-L1 cancer drug as Pfizer alliance ends
Endpoints
Merck KGaA
Pfizer
cancer
Bavencio
Flag link:
Merck KGaA pens $855M upfront, biobucks pact with Debiopharm for next-gen cancer asset
Merck KGaA pens $855M upfront, biobucks pact with Debiopharm for next-gen cancer asset
Fierce Biotech
Merck KGaA
Debiopharm
biobucks
Bavencio
Debio1143
xevinapant
Flag link:
ESMO: Pfizer, Merck KGaA's Bavencio comes up short against placebo in risky head and neck cancer trial
ESMO: Pfizer, Merck KGaA's Bavencio comes up short against placebo in risky head and neck cancer trial
Fierce Pharma
ESMO
Pfizer
Merck KGaA
Bavencio
head and neck cancer
clinical trials
Flag link:
ASCO: Pfizer, Merck KGaA's Bavencio posts win in rare gynecological cancer
ASCO: Pfizer, Merck KGaA's Bavencio posts win in rare gynecological cancer
Fierce Pharma
Pfizer
Merck KGaA
Bavencio
ASCO 2020
bladder cancer
gestational trophoblastic tumors
clinical trials
Flag link:
Bavencio from Merck KGaA, Pfizer encounters yet another trial setback
Bavencio from Merck KGaA, Pfizer encounters yet another trial setback
Endpoints
Merck KGaA
Pfizer
Bavencio
clinical trials
head and neck cancer
Flag link:
Merck KGaA, Pfizer's Bavencio set to seal bladder cancer approval after confirmatory trial scores
Merck KGaA, Pfizer's Bavencio set to seal bladder cancer approval after confirmatory trial scores
Endpoints
Merck KGaA
Pfizer
Bavencio
bladder cancer
FDA
Flag link:
Merck KGaA, Pfizer drug fails to meet endpoints in gastric cancer trial
Merck KGaA, Pfizer drug fails to meet endpoints in gastric cancer trial
Marketwatch
Merck KGaA
Pfizer
Bavencio
clinical trials
gastric cancer
Flag link:
Merck, Pfizer execs explain how they tap sites for cancer trials
Merck, Pfizer execs explain how they tap sites for cancer trials
Biopharma Dive
cancer
clinical trials
Pfizer
Merck
immuno-oncology
Bavencio
Keytruda
Flag link:
Merck and Pfizer’s Bavencio approved for renal cell carcinoma
Merck and Pfizer’s Bavencio approved for renal cell carcinoma
Pharmaforum
Merck KGaA
Pfizer
Bavencio
FDA
Inlyta
advanced renal cell carcinoma
Flag link:
Pfizer, Merck KGaA throw in the towel on another Bavencio PhIII as once bright hopes shrivel fast
Pfizer, Merck KGaA throw in the towel on another Bavencio PhIII as once bright hopes shrivel fast
Endpoints
Pfizer
Merck KGaA
ovarian cancer
Bavencio
Flag link:
As Pfizer kills failed PhIII programs for Bavencio, where do they go from here in R&D?
As Pfizer kills failed PhIII programs for Bavencio, where do they go from here in R&D?
Endpoints
Pfizer
Bavencio
R&D
Flag link:
Bavencio fails second ovarian cancer Phase III trial
Bavencio fails second ovarian cancer Phase III trial
BioCentury
Merck KGaA
Bavencio
ovarian cancer
Flag link:
Merck's Keytruda puts heat on Pfizer, Merck KGaA's Bavencio with new Merkel cell OK
Merck's Keytruda puts heat on Pfizer, Merck KGaA's Bavencio with new Merkel cell OK
Fierce Pharma
Merck
Keytruda
Pfizer
Merck KGaA
Bavencio
Merkel cell carcinoma
Flag link:
Pfizer's PARP, androgen inhibitors next combo partners for NKTR-214
Pfizer's PARP, androgen inhibitors next combo partners for NKTR-214
BioCentury
Pfizer
Nektar Therapeutics
NKTR-214
Xtandi
Talzenna
Bavencio
prostate cancer
Flag link:
Pfizer preps for BMS showdown with Bavencio kidney cancer combo data
Pfizer preps for BMS showdown with Bavencio kidney cancer combo data
Fierce Pharma
Pfizer
Bristol-Myers Squibb
kidney cancer
Bavencio
Flag link:
Merck KGaA, Pfizer's immuno-drug shown to alleviate kidney cancer
Merck KGaA, Pfizer's immuno-drug shown to alleviate kidney cancer
Yahoo/Reuters
Merck KGaA
Bavencio
Pfizer
kidney cancer
Inlyta
Flag link:
Merck's Keytruda threatens Pfizer, Merck KGaA's Bavencio with Merkel cell 'priority' tag
Merck's Keytruda threatens Pfizer, Merck KGaA's Bavencio with Merkel cell 'priority' tag
Fierce Pharma
Merck
Keytruda
Pfizer
Merck KGaA
Bavencio
Merkel cell carcinoma
FDA
Flag link:
How Pfizer Plans to Move Into the Big Leagues for Cancer Treatment
How Pfizer Plans to Move Into the Big Leagues for Cancer Treatment
Motley Fool
cancer
oncology
Pfizer
Ibrance
breast cancer
Xtandi
prostate cancer
Bavencio
bladder cancer
Merkel cell carcinoma
lorlatinib
metastatic non-small cell lung cancer
talazoparib
metastatic breast cancer
Flag link:
Pfizer, Merck KGaA nab NICE's favor for Bavencio in Merkel cell carcinoma
Pfizer, Merck KGaA nab NICE's favor for Bavencio in Merkel cell carcinoma
Fierce Pharma
Pfizer
Merck KGaA
NICE
Bavencio
Merkel cell carcinoma
Flag link:
FDA OK makes AstraZeneca the leader in one new segment of the all-important lung cancer market
FDA OK makes AstraZeneca the leader in one new segment of the all-important lung cancer market
Endpoints
FDA
AstraZeneca
Imfinzi
lung cancer
Bavencio
Pfizer
Merck KGaA
Flag link:

Pages